$NKE phase 1 done, this from 11/20/15 $NKE, Will be way

New Post Public Reply Private Reply Replies (1) Message Board
fitzkarz
$NKE phase 1 done, this from 11/20/15

$NKE, Will be way better interest on your money in next year.(then a bank)
Should gain 25 to 100% within a year, plus dividends!

$NKE solid investment with a nice return.
Nike Split Means Less Discretionary, More Industry in Dow Industrials -- Barron's Blog
14 hours 29 minutes ago - DJNF

By Ben Levisohn

After the close Nike ( NKE) announced that it would split its stock in two, buyback more share, and raise its dividend. Not only is has Nike's announcement made its shares more attractive to investors--its shares have jumped 3.2% to $129.82 at 5:08 p.m. in after-hours trading today--it will also reduce the consumer-discretionary sector's weight in the Dow Jones Industrial Average thanks to the benchmark's price weighting.

According to S&P Dow Jones Indices' Howard Silverblatt, Nike's stock split will reduce the weight of the consumer discretionary sector in the Dow Jones Industrial Average to 16.7% from 18.3%, while the Industrial Sector will rise from 19.1% to 20%. Consumer discretionary has a 12.5% weighting in the market-cap weighted S&P 500, while the industrial sector has a 10.3% weight.

Despite the fact that the raised dividends and increased buybacks are often signs that a company doesn't have as many growth opportunities, Nike CEO Mark Parker said that's not the case. "We are built for growth, while also staying committed to creating shareholder value over the long term," he said in a press release. "We've proven it time and again, having returned over $23 billion to shareholders over the last 14 years through share repurchases and dividends. Moving forward, we see even greater potential for NIKE as we continue to unlock new markets, new experiences and new products."

Investors sure don't seem to mind.

More at Barron's Stocks to Watch blog, http://blogs.barrons.com/stockstowatchtoday/

(END) Dow Jones Newswires

November 19, 2015 17:27 ET (22:27 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.

Read More: http://investorshangout.com/post/view?id=3353...z3s2UhgE2a


Read More: http://investorshangout.com/post/view?id=3354...z3s2UKS250

Read More: http://investorshangout.com/post/view?id=3354...z3vFDLZHmD

Read More: http://investorshangout.com/post/view?id=3439...z3vFDrUE2u
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 17

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 6

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 20

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Maven Pet's AI Paw-tnership: Changing Pet Care Landscape

Updated Category News Views 8

AI in the World of Doggie Docs In today's tech-driven world, pet owners are turning to artificial intelligence like never before. Forget flipping through outdated dog-care books—nearly half of us are drilling ChatGPT for health tips on our four-legged pals. Yes, it seems we’re asking an AI about Rover's health more than some other major life decisions. But let's face...

Continue Reading
Franco-Nevada's Q3 Results Loom: Investors Ready

Updated Category News Views 15

Gearing Up: Franco-Nevada's Q3 Numbers on the Horizon You know the drill! Franco-Nevada's third quarter results won't just trickle in—they'll set the tone for the months ahead. Mark your calendar: November 11th after the market closes is the magic hour when you'll get the skinny on their Q3 performance. The next morning, bright and early at 8:00 AM ET, they'll hash it...

Continue Reading
CMC Declares Dividend Amid Complex Outlook

Updated Category News Views 17

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 12

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 6

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
Home Buying: Unmasking All the Real Budget Costs

Updated Category News Views 2

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Continue Reading
ore News Articles